Bank of Montreal’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bank of Montreal’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.5K	Buy	653 +34	+5%	+$2.8K	﹤0.01%	3387
2026 Q1	$49K	Sell	619 -111	-15%	-$8.97K	﹤0.01%	3299
2025 Q4	$60K	Hold	730	–	–	﹤0.01%	3161
2025 Q3	$51K	Hold	730	–	–	﹤0.01%	3117
2025 Q2	$46.8K	Hold	730	–	–	﹤0.01%	3151
2025 Q1	$46.3K	Hold	730	–	–	﹤0.01%	3083
2024 Q4	$48.6K	Sell	730 -2,735	-79%	-$189K	﹤0.01%	3116
2024 Q3	$242K	Hold	3,465	–	–	﹤0.01%	2912
2024 Q2	$230K	Hold	3,465	–	–	﹤0.01%	2908
2024 Q1	$227K	Hold	3,465	–	–	﹤0.01%	2967
2023 Q4	$231K	Hold	3,465	–	–	﹤0.01%	3030
2023 Q3	$213K	Hold	3,465	–	–	﹤0.01%	3031
2023 Q2	$220K	Buy	3,465 +2,735	+375%	+$171K	﹤0.01%	3159
2023 Q1	$47.7K	Hold	730	–	–	﹤0.01%	3379
2022 Q4	$48.6K	Sell	730 -95	-12%	-$6.03K	﹤0.01%	3550
2022 Q3	$54K	Hold	825	–	–	﹤0.01%	3620
2022 Q2	$49K	Sell	825 -57	-6%	-$3.28K	﹤0.01%	3633
2022 Q1	$55K	Hold	882	–	–	﹤0.01%	3775
2021 Q4	$64K	Buy	882 +465	+112%	+$33.7K	﹤0.01%	3200
2021 Q3	$32K	Hold	417	–	–	﹤0.01%	3604
2021 Q2	$33K	Buy	+417	New	+$31K	﹤0.01%	3467
2016 Q4	–	Sell	-200	Closed	-$8K	–	4152
2016 Q3	$8K	Hold	200	–	–	﹤0.01%	3609
2016 Q2	$7K	Hold	200	–	–	﹤0.01%	3666
2016 Q1	$8K	Hold	200	–	–	﹤0.01%	3680
2015 Q4	$10K	Buy	+200	New	+$9.88K	﹤0.01%	3621
2014 Q3	–	Sell	-1,000	Closed	-$44K	–	4307
2014 Q2	$44K	Hold	1,000	–	–	﹤0.01%	3252
2014 Q1	$42K	Hold	1,000	–	–	﹤0.01%	3200
2013 Q4	$37K	Hold	1,000	–	–	﹤0.01%	2990
2013 Q3	$35K	Buy	+1,000	New	+$33.1K	﹤0.01%	2988

Other funds holding PBE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.75B AUM 28.61% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Bank of Montreal's PBE Position: Q2 2026 in Review

Bank of Montreal increased its Invesco Biotechnology & Genome ETF (PBE) stake by 5.5% in Q2 2026, buying an estimated $2.8K and bringing the position to 653 shares worth $58.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3387.

Bank of Montreal first reported a position in PBE in Q3 2013 and has held it in 29 quarters since. The position peaked at $242K in Q3 2024. 104 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

Bank of Montreal held 653 shares of Invesco Biotechnology & Genome ETF worth $58.5K as of Q2 2026.
Bank of Montreal bought 34 Invesco Biotechnology & Genome ETF shares in Q2 2026, an estimated $2.8K.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3387 holding.
Bank of Montreal first reported a position in Invesco Biotechnology & Genome ETF in Q3 2013 and has held it in 29 quarters since.
Bank of Montreal's Invesco Biotechnology & Genome ETF position peaked at $242K in Q3 2024.
104 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.